Integrated imaging of [11C]-PBR28 PET, MR diffusion and magnetic resonance spectroscopy 1H-MRS in amyotrophic lateral sclerosis

[1]  S. Paganoni,et al.  Integrated magnetic resonance imaging and [11C]‐PBR28 positron emission tomographic imaging in amyotrophic lateral sclerosis , 2018, Annals of neurology.

[2]  B. Rosen,et al.  Imaging of glia activation in people with primary lateral sclerosis , 2017, NeuroImage: Clinical.

[3]  Nicole R. Zürcher,et al.  Glial activation colocalizes with structural abnormalities in amyotrophic lateral sclerosis , 2016, Neurology.

[4]  R. Hinz,et al.  Comparative Evaluation of Three TSPO PET Radiotracers in a LPS-Induced Model of Mild Neuroinflammation in Rats , 2016, Molecular Imaging and Biology.

[5]  C. Granziera,et al.  In Vivo Imaging of Human Neuroinflammation. , 2016, ACS chemical neuroscience.

[6]  Stamatios N. Sotiropoulos,et al.  An integrated approach to correction for off-resonance effects and subject movement in diffusion MR imaging , 2016, NeuroImage.

[7]  Christer Halldin,et al.  Effect of the myeloperoxidase inhibitor AZD3241 on microglia: a PET study in Parkinson's disease. , 2015, Brain : a journal of neurology.

[8]  Bruce R. Rosen,et al.  Increased in vivo glial activation in patients with amyotrophic lateral sclerosis: Assessed with [11C]-PBR28 , 2015, NeuroImage: Clinical.

[9]  Kevin T. Chen,et al.  An SPM8-Based Approach for Attenuation Correction Combining Segmentation and Nonrigid Template Formation: Application to Simultaneous PET/MR Brain Imaging , 2014, The Journal of Nuclear Medicine.

[10]  Roger N Gunn,et al.  A Graphical Method to Compare the in vivo Binding Potential of PET Radioligands in the Absence of a Reference Region: Application to [11C]PBR28 and [18F]PBR111 for TSPO Imaging , 2014, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[11]  Stephen M. Smith,et al.  Permutation inference for the general linear model , 2014, NeuroImage.

[12]  A. Pestronk,et al.  TREM2 variant p.R47H as a risk factor for sporadic amyotrophic lateral sclerosis. , 2014, JAMA neurology.

[13]  Xin Yu,et al.  A combined DTI and structural MRI study in medicated-naïve chronic schizophrenia. , 2014, Magnetic Resonance Imaging.

[14]  C. Rae.  A Guide to the Metabolic Pathways and Function of Metabolites Observed in Human Brain 1H Magnetic Resonance Spectra , 2013, Neurochemical Research.

[15]  Mark Jenkinson,et al.  Whole-brain magnetic resonance spectroscopic imaging measures are related to disability in ALS , 2013, Neurology.

[16]  H. Weiner,et al.  Modulating inflammatory monocytes with a unique microRNA gene signature ameliorates murine ALS. , 2012, The Journal of clinical investigation.

[17]  Philippe Hantraye,et al.  Reactive Astrocytes Overexpress TSPO and Are Detected by TSPO Positron Emission Tomography Imaging , 2012, The Journal of Neuroscience.

[18]  J. Trojanowski,et al.  Microglial Activation Correlates with Disease Progression and Upper Motor Neuron Clinical Symptoms in Amyotrophic Lateral Sclerosis , 2012, PloS one.

[19]  V. Sossi,et al.  Technical performance evaluation of a human brain PET/MRI system , 2012, European Radiology.

[20]  Roger N Gunn,et al.  An 18-kDa Translocator Protein (TSPO) polymorphism explains differences in binding affinity of the PET radioligand PBR28 , 2011, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[21]  Gerhard Rammes,et al.  Translocator protein (18 kDa) (TSPO) as a therapeutic target for neurological and psychiatric disorders , 2010, Nature Reviews Drug Discovery.

[22]  Ciprian Catana,et al.  Toward Implementing an MRI-Based PET Attenuation-Correction Method for Neurologic Studies on the MR-PET Brain Prototype , 2010, The Journal of Nuclear Medicine.

[23]  D. Dobrota,et al.  Proton magnetic resonance spectroscopy in patients with early stages of amyotrophic lateral sclerosis , 2010, Neuroradiology.

[24]  Masahiro Fujita,et al.  Comparison of [11C]-(R)-PK 11195 and [11C]PBR28, two radioligands for translocator protein (18 kDa) in human and monkey: Implications for positron emission tomographic imaging of this inflammation biomarker , 2010, NeuroImage.

[25]  Jing Han,et al.  Study of the features of proton MR spectroscopy (1H‐MRS) on amyotrophic lateral sclerosis , 2010, Journal of magnetic resonance imaging : JMRI.

[26]  Stephen M. Smith,et al.  Threshold-free cluster enhancement: Addressing problems of smoothing, threshold dependence and localisation in cluster inference , 2009, NeuroImage.

[27]  H. Urbach,et al.  Combined 3T Diffusion Tensor Tractography and 1H-MR Spectroscopy in Motor Neuron Disease , 2008, American Journal of Neuroradiology.

[28]  Sami S Zoghbi,et al.  Synthesis and evaluation in monkey of two sensitive 11C-labeled aryloxyanilide ligands for imaging brain peripheral benzodiazepine receptors in vivo. , 2008, Journal of medicinal chemistry.

[29]  Jeih-San Liow,et al.  Radiation Dosimetry and Biodistribution in Monkey and Man of 11C-PBR28: A PET Radioligand to Image Inflammation , 2007, Journal of Nuclear Medicine.

[30]  J. Moffett,et al.  N-Acetylaspartate in the CNS: From neurodiagnostics to neurobiology , 2007, Progress in Neurobiology.

[31]  Robert B. Innis,et al.  PET imaging with [11C]PBR28 can localize and quantify upregulated peripheral benzodiazepine receptors associated with cerebral ischemia in rat , 2007, Neuroscience Letters.

[32]  C. Hanstock,et al.  Detection of cerebral degeneration in amyotrophic lateral sclerosis using high-field magnetic resonance spectroscopy. , 2006, Archives of neurology.

[33]  G. Kollias,et al.  Onset and Progression in Inherited ALS Determined by Motor Neurons and Microglia , 2006, Science.

[34]  R B Banati,et al.  Mills’ and other isolated upper motor neurone syndromes: in vivo study with 11C-(R)-PK11195 PET , 2005, Journal of Neurology, Neurosurgery & Psychiatry.

[35]  F. Turkheimer,et al.  Evidence of widespread cerebral microglial activation in amyotrophic lateral sclerosis: an [11C](R)-PK11195 positron emission tomography study , 2004, Neurobiology of Disease.

[36]  D. Leibfritz,et al.  Interactions of Triethyltin-Chloride (TET) with the Energy Metabolism of Cultured Rat Brain Astrocytes: Studies by Multinuclear Magnetic Resonance Spectroscopy , 1997, Neurochemical Research.

[37]  S. Appel,et al.  Immune reactivity in a mouse model of familial ALS correlates with disease progression , 2001, Neurology.

[38]  T. Pabst,et al.  1H Spectroscopy in Patients With Amyotrophic Lateral Sclerosis , 2001, Journal of neuroimaging : official journal of the American Society of Neuroimaging.

[39]  H. Schild,et al.  Proton magnetic resonance spectroscopy of the motor cortex in 70 patients with amyotrophic lateral sclerosis. , 2001, Archives of neurology.

[40]  B Y Yeap,et al.  Robust Two‐Stage Estimation in Hierarchical Nonlinear Models , 2001, Biometrics.

[41]  M. Swash,et al.  El Escorial revisited: Revised criteria for the diagnosis of amyotrophic lateral sclerosis , 2000, Amyotrophic lateral sclerosis and other motor neuron disorders : official publication of the World Federation of Neurology, Research Group on Motor Neuron Diseases.

[42]  J. Cedarbaum,et al.  The ALSFRS-R: a revised ALS functional rating scale that incorporates assessments of respiratory function , 1999, Journal of the Neurological Sciences.

[43]  Robert A. Zimmerman,et al.  Proton magnetic resonance spectroscopy , 1999, Critical reviews in neurosurgery : CR.

[44]  J. Haines,et al.  Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis , 1993, Nature.